These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37168102)

  • 21. Equipping providers to offer novel MPTs: Developing counseling messages for the Dual Prevention Pill in clinical studies and beyond.
    Segal K; Harris DM; Carmone A; Haddad LB; Hadigal S; Hatzold K; Jones C; Lathrop E; Mason J; Mikulich M
    Front Reprod Health; 2023; 5():1155948. PubMed ID: 37284490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Young Women's Ratings of Three Placebo Multipurpose Prevention Technologies for HIV and Pregnancy Prevention in a Randomized, Cross-Over Study in Kenya and South Africa.
    Minnis AM; Roberts ST; Agot K; Weinrib R; Ahmed K; Manenzhe K; Owino F; van der Straten A;
    AIDS Behav; 2018 Aug; 22(8):2662-2673. PubMed ID: 29560570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perceptions of and interest in HIV pre-exposure prophylaxis use among adolescent girls and young women in Lilongwe, Malawi.
    Maseko B; Hill LM; Phanga T; Bhushan N; Vansia D; Kamtsendero L; Pettifor AE; Bekker LG; Hosseinipour MC; Rosenberg NE
    PLoS One; 2020; 15(1):e0226062. PubMed ID: 31929547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strengthening health system's capacity for pre-exposure prophylaxis for adolescent girls and young women and adolescent boys and young men in South Africa (SHeS'Cap-PrEP): Protocol for a mixed methods study in KwaZulu-Natal, South Africa.
    Nicol E; Ramraj T; Hlongwa M; Basera W; Jama N; Lombard C; McClinton-Appollis T; Govindasamy D; Pass D; Funani N; Aheron S; Paredes-Vincent A; Drummond J; Cheyip M; Dladla S; Bedford J; Mathews C
    PLoS One; 2022; 17(3):e0264808. PubMed ID: 35298487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acceptability and usability of oral fluid-based HIV self-testing among female sex workers and men who have sex with men in Morocco.
    Ben Moussa A; Belhiba O; Hajouji FZ; El Kettani A; Youbi M; Alami K; El Omari B; Ouarsas L; Karkouri M
    BMC Public Health; 2022 Dec; 22(1):2266. PubMed ID: 36471285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Key influences on the decision to initiate PrEP among adolescent girls and young women within routine maternal child health and family planning clinics in Western Kenya.
    Rogers Z; Pintye J; Kinuthia J; O'Malley G; Abuna F; Escudero J; Mugambi M; Awuor M; Dollah A; Dettinger JC; Kohler P; John-Stewart G; Beima-Sofie K
    AIDS Care; 2022 Mar; 34(3):363-370. PubMed ID: 34543077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From policy to practice: uptake of pre-exposure prophylaxis among adolescent girls and young women in United States President's Emergency Plan for AIDS Relief-supported countries, 2017-2020.
    Patel P; Sato K; Bhandari N; Kanagasabai U; Schelar E; Cooney C; Eakle R; Klucking S; Toiv N; Saul J;
    AIDS; 2022 Jun; 36(Suppl 1):S15-S26. PubMed ID: 35766572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. End-Users' Product Preference Across Three Multipurpose Prevention Technology Delivery Forms: Baseline Results from Young Women in Kenya and South Africa.
    Weinrib R; Minnis A; Agot K; Ahmed K; Owino F; Manenzhe K; Cheng H; van der Straten A
    AIDS Behav; 2018 Jan; 22(1):133-145. PubMed ID: 29052018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV prevention at drug shops: awareness and attitudes among shop dispensers and young women about oral pre-exposure prophylaxis and the dapivirine ring in Shinyanga, Tanzania.
    Tubert J; Packel L; Hunter LA; Mfaume R; Njau P; Ramadhani AA; Liu JX; McCoy SI
    AIDS Res Ther; 2021 Apr; 18(1):21. PubMed ID: 33902623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa.
    Nyblade L; Ndirangu JW; Speizer IS; Browne FA; Bonner CP; Minnis A; Kline TL; Ahmed K; Howard BN; Cox EN; Rinderle A; Wechsberg WM
    BMC Public Health; 2022 Oct; 22(1):1916. PubMed ID: 36242000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health care providers' attitudes toward and experiences delivering oral PrEP to adolescent girls and young women in Kenya, South Africa, and Zimbabwe.
    Lanham M; Ridgeway K; Mireku M; Nhamo D; Pillay D; Murire M; Stankevitz K; Kyongo J; Mullick S;
    BMC Health Serv Res; 2021 Oct; 21(1):1112. PubMed ID: 34663320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mobile App (UPrEPU) to Monitor Adherence to Pre-exposure Prophylaxis in Men Who Have Sex With Men: Protocol for a User-Centered Approach to Mobile App Design and Development.
    Strong C; Wu HJ; Tseng YC; Yuan CW; Yu YF; Liao JC; Chen YW; Hung YC; Li CW; Huang PH; Ko NY; Ku SW
    JMIR Res Protoc; 2020 Dec; 9(12):e20360. PubMed ID: 33258793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interest in multipurpose prevention technologies to prevent HIV/STIs and unintended pregnancy among young women in the United States.
    Hynes JS; Sales JM; Sheth AN; Lathrop E; Haddad LB
    Contraception; 2018 Mar; 97(3):277-284. PubMed ID: 29055782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferred Product Attributes of Potential Multipurpose Prevention Technologies for Unintended Pregnancy and Sexually Transmitted Infections or HIV Among U.S. Women.
    Hynes JS; Sheth AN; Lathrop E; Sales JM; Haddad LB
    J Womens Health (Larchmt); 2019 May; 28(5):665-672. PubMed ID: 30615569
    [No Abstract]   [Full Text] [Related]  

  • 35. Health Care Providers as Agents of Change: Integrating PrEP With Other Sexual and Reproductive Health Services for Adolescent Girls and Young Women.
    O'Malley G; Beima-Sofie KM; Roche SD; Rousseau E; Travill D; Omollo V; Delany-Moretlwe S; Bekker LG; Bukusi EA; Kinuthia J; Barnabee G; Dettinger JC; Wagner AD; Pintye J; Morton JF; Johnson RE; Baeten JM; John-Stewart G; Celum CL
    Front Reprod Health; 2021; 3():668672. PubMed ID: 36303982
    [No Abstract]   [Full Text] [Related]  

  • 36. Usability and Acceptability of a Mobile Comprehensive HIV Prevention App for Men Who Have Sex With Men: A Pilot Study.
    Sullivan PS; Driggers R; Stekler JD; Siegler A; Goldenberg T; McDougal SJ; Caucutt J; Jones J; Stephenson R
    JMIR Mhealth Uhealth; 2017 Mar; 5(3):e26. PubMed ID: 28279949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship dynamics and anticipated stigma: Key considerations for PrEP use among Tanzanian adolescent girls and young women and male partners.
    Jani N; Mathur S; Kahabuka C; Makyao N; Pilgrim N
    PLoS One; 2021; 16(2):e0246717. PubMed ID: 33596216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of the dual prevention pill for contraception and HIV pre-exposure prophylaxis.
    Milali MP; Resar D; Kaftan D; Campbell J; Olowu A; Edwards D; Platais I; Kim HY; Jenkins S; Bershteyn A
    Front Reprod Health; 2023; 5():1144217. PubMed ID: 37266447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV risk, risk perception, and PrEP interest among adolescent girls and young women in Lilongwe, Malawi: operationalizing the PrEP cascade.
    Hill LM; Maseko B; Chagomerana M; Hosseinipour MC; Bekker LG; Pettifor A; Rosenberg NE
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25502. PubMed ID: 32602649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Planning for decentralized, simplified prEP: Learnings from potential end users in Ga-Rankuwa, gauteng, South Africa.
    Mataboge P; Nzenze S; Mthimkhulu N; Mazibuko M; Kutywayo A; Butler V; Naidoo N; Mullick S
    Front Reprod Health; 2022; 4():1081049. PubMed ID: 36699142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.